News
Videos
Conferences
Events
Resources
Subscribe

|Videos|January 14, 2016

Understanding and Managing Relapse

Episodes in this series

EP. 1 Multiple Myeloma Defined

EP. 1 Multiple Myeloma Defined

EP. 2 The Detection of Multiple Myeloma

EP. 2 The Detection of Multiple Myeloma

EP. 3 Understanding Your Bone Marrow Biopsy

EP. 3 Understanding Your Bone Marrow Biopsy

EP. 4 Initial Reactions Upon a Diagnosis

EP. 4 Initial Reactions Upon a Diagnosis

EP. 5 Managing Multiple Myeloma

EP. 5 Managing Multiple Myeloma

EP. 6 Managing Side Effects

EP. 6 Managing Side Effects

EP. 7 Education Is Power

EP. 7 Education Is Power

EP. 8 Preventive Measures of Stem Cell Transplants

EP. 8 Preventive Measures of Stem Cell Transplants

EP. 9 Stem Cell Transplantation: What to Expect After

EP. 9 Stem Cell Transplantation: What to Expect After

EP. 10 Stem Cell Transplantation: Preventive Measures

EP. 10 Stem Cell Transplantation: Preventive Measures

EP. 11 Understanding and Managing Relapse

EP. 11 Understanding and Managing Relapse

EP. 12 Setting Realistic Expectations After Diagnosis

EP. 12 Setting Realistic Expectations After Diagnosis

EP. 13 Considerations to Optimize Your Health

EP. 13 Considerations to Optimize Your Health

null

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Saad Usmani

KTX-1001 Elicits Responses in Some With Multiple Myeloma

February 5th 2026

Ronald Chin

Thoughts about Relapse of Multiple Myeloma

February 5th 2026

blood test

Noninvasive Blood Test Launched for Myeloma MRD Monitoring

February 3rd 2026

Dr. Saad Usmani

What is the Goal of Multiple Myeloma Treatment?

BySaad Usmani, MD

February 3rd 2026

Biotin supplements used for cancer-related hair loss may interfere with key blood tests, risking inaccurate results and altered care decisions: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin Supplements May Complicate Cancer Care, Research Shows

February 2nd 2026

Trending on CURE

FDA Updates Safety Warnings for Common Chemotherapy Drugs

New Combination Treatment Approach Studied in Pancreatic Cancer

KTX-1001 Elicits Responses in Some With Multiple Myeloma

Biomarker-Free Relacorilant Combo Broadens Options in Ovarian Cancer

FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma